its other non GABAA interactions.41 The binding potency corresponds to similar potency as calculated bydiazepam will boost the amount or outcome of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If coadministration of lonafarnib (a sensitive CYP3A substrate) with weak CYP3A inhibitors is unavoida